April 14, 2020 | 9:38pm | Updated April 15, 2020 | 3:06am Enlarge Image Two kids wearing masks in Central Park. Taidgh Barron/NY Post Most New York children “probably” already have coronavirus and are serving as vectors to spread the disease, according to one New York pediatrician. Dr. Dyan Hes at New York City’s Gramercy…
April 14, 2020 | 9:38pm Enlarge Image Two kids wearing masks in Central Park. Taidgh Barron/NY Post Most New York children “probably” already have coronavirus and are serving as vectors to spread the disease, according to one New York pediatrician. Dr. Dyan Hes at New York City’s Gramercy Pediatrics advised parents to assume their children…
April 14, 2020 | 9:38pm Enlarge Image Two kids wearing masks in Central Park. Taidgh Barron/NY Post Most New York children “probably” already have coronavirus and are serving as vectors to spread the disease, according to one New York pediatrician. Dr. Dyan Hes at New York City’s Gramercy Pediatrics advised parents to assume their children…
April 14, 2020 | 9:38pm Enlarge Image Two kids wearing masks in Central Park. Taidgh Barron/NY Post Most New York children “probably” already have coronavirus and are serving as vectors to spread the disease, according to one New York pediatrician. Dr. Dyan Hes at New York City’s Gramercy Pediatrics advised parents to assume their children…
Robert F. Kennedy Jr. has rightly made “radical transparency” the motto of his Department of Health and Human Services. HHS even has a page by that name. I think it is a good motto, and I want to help Secretary Kennedy and Acting FDA Commissioner Kyle Diamantas deliver on it in food safety, with two citizen petitions
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment